|
1
|
Zent CS and Elliott MR: Maxed out macs:
Physiologic cell clearance as a function of macrophage phagocytic
capacity. FEBS J. 284:1021–1039. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang Q, L Y, Bian H, Guo L and Zhu H:
Activation of the α7 nicotinic receptor promotes
lipopolysaccharide-induced conversion of M1 microglia to M2. Am J
Transl Res. 9:971–985. 2017.PubMed/NCBI
|
|
3
|
Yao Y, Xu XH and Jin L: Macrophage
Polarization in physiological and pathological pregnancy. Front
Immunol. 10:7922019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gordon S: Alternative activation of
macrophages. Nat Rev Immunol. 3:23–35. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gensel JC and Zhang B: Macrophage
activation and its role in repair and pathology after spinal cord
injury. Brain Res. 1619:1–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lefèvre L, Lugo-Villarino G, Meunier E,
Valentin A, Olagnier D, Authier H, Duval C, Dardenne C, Bernad J,
Lemesre JL, et al: The C-type lectin receptors dectin-1, MR, and
SIGNR3 contribute both positively and negatively to the macrophage
response to Leishmania infantum. Immunity. 38:1038–1049. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang LX, Zhang SX, Wu HJ, Rong XL and Guo
J: M2b macrophage polarization and its roles in diseases. J Leukoc
Biol. 106:345–358. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Y, Smith W, Hao D, He B and Kong L:
M1 and M2 macrophage polarization and potentially therapeutic
naturally occurring compounds. Int Immunopharmacol. 70:459–466.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang L and Zhang Y: Tumor-associated
macrophages: From basic research to clinical application. J Hematol
Oncol. 10:582017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ferrante CJ, Pinhal-Enfield G, Elson G,
Cronstein BN, Hasko G, Outram S and Leibovich SJ: The
adenosine-dependent angiogenic switch of macrophages to an M2-like
phenotype is independent of interleukin-4 receptor alpha (IL-4Rα)
signaling. Inflammation. 36:921–931. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mills CD, Lenz LL and Harris RA: A
breakthrough: Macrophage-directed cancer immunotherapy. Cancer Res.
76:513–516. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Herwig MC, Bergstrom C, Wells JR, Höller T
and Grossniklaus HE: M2/M1 ratio of tumor associated macrophages
and PPAR-gamma expression in uveal melanomas with class 1 and class
2 molecular profiles. Exp Eye Res. 107:52–58. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang HC, Chen CW, Yang CL, Tsai IM, Hou
YC, Chen CJ and Shan YS: Tumor-associated macrophages promote
epigenetic silencing of gelsolin through DNA methyltransferase 1 in
gastric cancer cells. Cancer Immunol Res. 5:885–897. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sarode P, Zheng X, Giotopoulou GA, Weigert
A, Kuenne C, Günther S, Friedrich A, Gattenlöhner S, Stiewe T,
Brüne B, et al: Reprogramming of tumor-associated macrophages by
targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment
of lung cancer. Sci Adv. 6:eaaz61052020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li X, Liu R, Su X, Pan Y, Han X, Shao C
and Shi Y: Harnessing tumor-associated macrophages as aids for
cancer immunotherapy. Mol Cancer. 18:1772019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Larionova I, Cherdyntseva N, Liu T,
Patysheva M, Rakina M and Kzhyshkowska J: Interaction of
tumor-associated macrophages and cancer chemotherapy.
Oncoimmunology. 8:15960042019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee HW, Choi HJ, Ha SJ, Lee KT and Kwon
YG: Recruitment of monocytes/macrophages in different tumor
microenvironments. Biochim Biophys Acta. 1835:170–179.
2013.PubMed/NCBI
|
|
18
|
Fantuzzi L, Tagliamonte M, Gauzzi MC and
Lopalco L: Dual CCR5/CCR2 targeting: Opportunities for the cure of
complex disorders. Cell Mol Life Sci. 76:4869–4886. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vogel DY, Heijnen PD, Breur M, de Vries
HE, Tool AT, Amor S and Dijkstra CD: Macrophages migrate in an
activation-dependent manner to chemokines involved in
neuroinflammation. J Neuroinflammation. 11:232014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Byrne SN, Knox MC and Halliday GM: TGFbeta
is responsible for skin tumour infiltration by macrophages enabling
the tumours to escape immune destruction. Immunol Cell Biol.
86:92–97. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tang M, Liu B, Bu X and Zhao P: Cross-talk
between ovarian cancer cells and macrophages through periostin
promotes macrophage recruitment. Cancer Sci. 109:1309–1318. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ruffell B, Affara NI and Coussens LM:
Differential macrophage programming in the tumor microenvironment.
Trends Immunol. 33:119–126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Henze AT and Mazzone M: The impact of
hypoxia on tumor- associated macrophages. J Clin Invest.
26:3672–3679. 2016. View Article : Google Scholar
|
|
24
|
Casazza A, Laoui D, Wenes M, Rizzolio S,
Bassani N, Mambretti M, Deschoemaeker S, Van Ginderachter JA,
Tamagnone L and Mazzone M: Impeding macrophage entry into hypoxic
tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis
and restores antitumor immunity. Cancer Cell. 24:695–709. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Clarijs R, Schalkwijk L, Ruiter DJ and de
Waal RM: EMAP-II expression is associated with macrophage
accumulation in primary uveal melanoma. Invest Ophthalmol Vis Sci.
44:1801–1816. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huber R, Meier B, Otsuka A, Fenini G,
Satoh T, Gehrke S, Widmer D, Levesque MP, Mangana J, Kerl K, et al:
Tumour hypoxia promotes melanoma growth and metastasis via high
mobility group box-1 and M2-like macrophages. Sci Rep. 6:299142016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tang C, Liu T, Wang K, Wang X, Xu S, He D
and Zeng J: Transcriptional regulation of FoxM1 by HIF-1α mediates
hypoxia-induced EMT in prostate cancer. Oncol Rep. 42:1307–1318.
2019.PubMed/NCBI
|
|
28
|
Schmid MC, Avraamides CJ, Dippold HC,
Franco I, Foubert P, Ellies LG, Acevedo LM, Manglicmot JR, Song X,
Wrasidlo W, et al: Receptor tyrosine kinases and TLR/IL1Rs
unexpectedly activate myeloid cell PI3kγ, a single convergent point
promoting tumor inflammation and progression. Cancer Cell.
19:715–727. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: Regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Arendt LM, McCready J, Keller PJ, Baker
DD, Naber SP, Seewaldt V and Kuperwasser C: Obesity promotes breast
cancer by CCL2-mediated macrophage recruitment and angiogenesis.
Cancer Res. 73:6080–6093. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hao J, Yan F, Zhang Y, Triplett A, Zhang
Y, Schultz DA, Sun Y, Zeng J, Silverstein KAT, Zheng Q, et al:
Expression of adipocyte/macrophage fatty acid binding protein in
tumor associated macrophages promotes breast cancer progression.
Cancer Res. 78:2343–2355. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Komohara Y and Takeya M: CAFs and TAMs:
Maestros of the tumour microenvironment. J Pathol. 241:313–315.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Miyake M, Hori S, Morizawa Y, Tatsumi Y,
Nakai Y, Anai S, Torimoto K, Aoki K, Tanaka N, Shimada K, et al:
CXCL1-mediated interaction of cancer cells with tumor-associated
macrophages and cancer-associated fibroblasts promotes tumor
progression in human bladder cancer. Neoplasia. 18:636–646. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wan S, Zhao E, Kryczek I, Vatan L,
Sadovskaya A, Ludema G, Simeone DM, Zou W and Welling TH:
Tumor-associated macrophages produce interleukin 6 and signal via
STAT3 to promote expansion of human hepatocellular carcinoma stem
cells. Gastroenterology. 147:1393–1404. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yi L, Xiao H, Xu M, Ye X, Hu J, Li F, Li
M, Luo C, Yu S, Bian X and Feng H: Glioma-initiating cells: A
predominant role in microglia/macrophages tropism to glioma. J
Neuroimmunol. 232:75–82. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Biswas SK and Mantovani A: Macrophage
plasticity and interaction with lymphocyte subsets: Cancer as a
paradigm. Nat Immunol. 11:889–896. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Murray PJ: Macrophage polarization. Annu
Rev Physiol. 79:541–566. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen JJ, Yao PL, Yuan A, Hong TM, Shun CT,
Kuo ML, Lee YC and Yang PC: Up-regulation of tumor interleukin-8
expression by infiltrating macrophages: Its correlation with tumor
angiogenesis and patient survival in non-small cell lung cancer.
Clin Cancer Res. 9:729–737. 2003.PubMed/NCBI
|
|
39
|
Noy R and Pollard JW: Tumor-associated
macrophages: From mechanisms to therapy. Immunity. 41:49–61. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu YC, Zou XB, Chai YF and Yao YM:
Macrophage polarization in inflammatory diseases. Int J Biol Sci.
10:520–529. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li X, Luo H, Ye Y, Chen X, Zou Y, Duan J
and Xiang D: β-glucan, a dectin-1 ligand, promotes macrophage M1
polarization via NF-κB/autophagy pathway. Int J Oncol. 54:271–282.
2019.PubMed/NCBI
|
|
42
|
Su S, Liu Q, Chen J, Chen J, Chen F, He C,
Huang D, Wu W, Lin L, Huang W, et al: A positive feedback loop
between mesenchymal-like cancer cells and macrophages is essential
to breast cancer metastasis. Cancer Cell. 25:605–620. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Pan Z, Tian Y, Niu G and Cao C: Role of
microRNAs in remodeling the tumor microenvironment. Int J Oncol.
56:407–416. 2020.PubMed/NCBI
|
|
44
|
Peng D, Kryczek I, Nagarsheth N, Zhao L,
Wei S, Wang W, Sun Y, Zhao E, Vatan L, Szeliga W, et al: Epigenetic
silencing of TH1-type chemokines shapes tumour immunity and
immunotherapy. Nature. 527:249–253. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lawrence T and Natoli G: Transcriptional
regulation of macrophage polarization: Enabling diversity with
identity. Nat Rev Immunol. 11:750–761. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Heusinkveld M and van der Burg SH:
Identification and manipulation of tumor associated macrophages in
human cancers. J Transl Med. 9:2162011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Rolny C, Mazzone M, Tugues S, Laoui D,
Johansson I, Coulon C, Squadrito ML, Segura I, Li X, Knevels E, et
al: HRG inhibits tumor growth and metastasis by inducing macrophage
polarization and vessel normalization through downregulation of
PlGF. Cancer Cell. 19:31–44. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Jiang S, Yang Y, Fang M, Li X, Yuan X and
Yuan J: Co-evolution of tumor-associated macrophages and tumor
neo-vessels during cervical cancer invasion. Oncol Lett.
12:2625–2631. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wyckoff JB, Wang Y, Lin EY, Li JF, Goswami
S, Stanley ER, Segall JE, Pollard JW and Condeelis J: Direct
visualization of macrophage-assisted tumor cell intravasation in
mammary tumors. Cancer Res. 67:2649–2656. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Caux C, Ramos RN, Prendergast GC,
Bendriss-Vermare N and Ménétrier-Caux C: A Milestone review on how
macrophages affect tumor growth. Cancer Res. 76:6439–6442. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Du R, Lu KV, Petritsch C, Liu P, Ganss R,
Passegué E, Song H, Vandenberg S, Johnson RS, Werb Z and Bergers G:
HIF1alpha induces the recruitment of bone marrow-derived vascular
modulatory cells to regulate tumor angiogenesis and invasion.
Cancer Cell. 13:206–220. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Stockmann C, Doedens A, Weidemann A, Zhang
N, Takeda N, Greenberg JI, Cheresh DA and Johnson RS: Deletion of
vascular endothelial growth factor in myeloid cells accelerates
tumorigenesis. Nature. 456:814–818. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Lin L, Chen YS, Yao YD, Chen JQ, Chen JN,
Huang SY, Zeng YJ, Yao HR, Zeng SH, Fu YS and Song EW: CCL18 from
tumor-associated macrophages promotes angiogenesis in breast
cancer. Oncotarget. 6:34758–34773. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Saharinen P, Bry M and Alitalo K: How do
angiopoietins Tie with vascular endothelial growth factors? Curr
Opin Hematol. 17:198–205. 2010.PubMed/NCBI
|
|
55
|
Chen Y, Song Y, Du W, Gong L, Chang H and
Zou Z: Tumor-associated macrophages: An accomplice in solid tumor
progression. J Biomed Sci. 26:782019. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Mazzieri R, Pucci F, Moi D, Zonari E,
Ranghetti A, Berti A, Politi LS, Gentner B, Brown JL, Naldini L and
De Palma M: Targeting the ANG2/TIE2 axis inhibits tumor growth and
metastasis by impairing angiogenesis and disabling rebounds of
proangiogenic myeloid cells. Cancer Cell. 19:512–526. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Dirkx AE, Oude Egbrink MG, Wagstaff J and
Griffioen AW: Monocyte/macrophage infiltration in tumors:
Modulators of angiogenesis. J Leukoc Biol. 80:1183–1196. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Wyckoff J, Wang W, Lin EY, Wang Y, Pixley
F, Stanley ER, Graf T, Pollard JW, Segall J and Condeelis J: A
paracrine loop between tumor cells and macrophages is required for
tumor cell migration in mammary tumors. Cancer Res. 64:7022–7029.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Gocheva V, Wang HW, Gadea BB, Shree T,
Hunter KE, Garfall AL, Berman T and Joyce JA: IL-4 induces
cathepsin protease activity in tumor-associated macrophages to
promote cancer growth and invasion. Genes Dev. 24:241–255. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
DeNardo DG, Barreto JB, Andreu P, Vasquez
L, Tawfik D, Kolhatkar N and Coussens LM: CD4(+) T cells regulate
pulmonary metastasis of mammary carcinomas by enhancing protumor
properties of macrophages. Cancer Cell. 16:91–102. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Hernandez L, Smirnova T, Kedrin D, Wyckoff
J, Zhu L, Stanley ER, Cox D, Muller WJ, Pollard JW, Van Rooijen N
and Segall JE: The EGF/CSF-1 paracrine invasion loop can be
triggered by heregulin beta1 and CXCL12. Cancer Res. 69:3221–3227.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Kim S, Takahashi H, Lin WW, Descargues P,
Grivennikov S, Kim Y, Luo JL and Karin M: Carcinoma-produced
factors activate myeloid cells through TLR2 to stimulate
metastasis. Nature. 457:102–106. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Yan D, Wang HW, Bowman RL and Joyce JA:
STAT3 and STAT6 signaling pathways synergize to promote cathepsin
secretion from macrophages via IRE1α activation. Cell Rep.
16:2914–2927. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Quintero-Fabián S, Arreola R,
Becerril-Villanueva E, Torres-Romero JC, Arana-Argáez V,
Lara-Riegos J, Ramírez-Camacho MA and Alvarez-Sánchez ME: Role of
matrix metalloproteinases in angiogenesis and cancer. Front Oncol.
9:13702019. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Jiang D, Liang J and Noble PW: Hyaluronan
as an immune regulator in human diseases. Physiol Rev. 91:221–264.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Wang N, Liu W, Zheng Y, Wang S, Yang B, Li
M, Song J, Zhang F, Zhang X, Wang Q and Wang Z: CXCL1 derived from
tumor-associated macrophages promotes breast cancer metastasis via
activating NF-κB/SOX4 signaling. Cell Death Dis. 9:8802018.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Izumi K and Mizokami A: Suppressive role
of androgen/androgen receptor signaling via chemokines on prostate
cancer cells. J Clin Med. 8:3542019. View Article : Google Scholar
|
|
69
|
Wang D, Sun H, Wei J, Cen B and DuBois RN:
CXCL1 is critical for premetastatic niche formation and metastasis
in colorectal cancer. Cancer Res. 13:3655–3665. 2017. View Article : Google Scholar
|
|
70
|
Kawano M, Mabuchi S, Matsumoto Y, Sasano
T, Takahashi R, Kuroda H, Kozasa K, Hashimoto K, Isobe A, Sawada K,
et al: The significance of G-CSF expression and myeloid-derived
suppressor cells in the chemoresistance of uterine cervical cancer.
Sci Rep. 5:182172015. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Rőszer T: Understanding the mysterious M2
macrophage through activation markers and effector mechanisms.
Mediators Inflamm. 2015:8164602015. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Okeke EB and Uzonna JE: The pivotal role
of regulatory T cells in the regulation of innate immune cells.
Front Immunol. 10:6802019. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Hoves S, Ooi CH, Wolter C, Sade H,
Bissinger S, Schmittnaegel M, Ast O, Giusti AM, Wartha K, Runza V,
et al: Rapid activation of tumor-associated macrophages boosts
preexisting tumor immunity. J Exp Med. 215:859–876. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Ma X, Yan W, Zheng H, Du Q, Zhang L, Ban
Y, Li N and Wei F: Regulation of IL-10 and IL-12 production and
function in macrophages and dendritic cells 4. F1000 Faculty
Rev-1465. 2015.
|
|
75
|
Kanamori M, Nakatsukasa H, Okada M, Lu Q
and Yoshimura A: Induced regulatory T Cells: Their development,
stability, and applications. Trends Immunol. 37:803–811. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Chanmee T, Ontong P, Konno K and Itano N:
Tumor-associated macrophages as major players in the tumor
microenvironment. Cancers (Basel). 6:1670–1690. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Zhang J, Shi Z, Xu X, Yu Z and Mi J: The
influence of microenvironment on tumor immunotherapy. FEBS J.
286:4160–4175. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Czystowska-Kuzmicz M, Sosnowska A, Nowis
D, Ramji K, Szajnik M, Chlebowska-Tuz J, Wolinska E, Gaj P, Grazul
M, Pilch Z, et al: Small extracellular vesicles containing
arginase-1 suppress T-cell responses and promote tumor growth in
ovarian carcinoma. Nat Commun. 10:30002019. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Pathria P, Louis TL and Varner JA:
Targeting tumor-associated macrophages in cancer. Trends Immunol.
40:310–327. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Zhang D, Shi R, Xiang W, Kang X, Tang B,
Li C, Gao L, Zhang X, Zhang L, Dai R and Miao H: The Agpat4/LPA
axis in colorectal cancer cells regulates antitumor responses via
p38/p65 signaling in macrophages. Signal Transduct Target Ther.
5:242020. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Vinogradov S, Warren G and Wei X:
Macrophages associated with tumors as potential targets and
therapeutic intermediate. Nanomedicine (Lond). 9:695–707. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Nywening TM, Belt BA, Cullinan DR, Panni
RZ, Han BJ, Sanford DE, Jacobs RC, Ye J, Patel AA, Gillanders WE,
et al: Targeting both tumour-associated CXCR2+
neutrophils and CCR2+ macrophages disrupts myeloid
recruitment and improves chemotherapeutic responses in pancreatic
ductal adenocarcinoma. Gut. 67:1112–1123. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Lee C, Jeong H, Bae Y, Shin K, Kang S, Kim
H, Oh J and Bae H: Targeting of M2-like tumor-associated
macrophages with a melittin-based pro-apoptotic peptide. J
Immunother Cancer. 7:1472019. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Andersen MN, Etzerodt A, Graversen JH,
Holthof LC, Moestrup SK, Hokland M and Møller HJ: STAT3 inhibition
specifically in human monocytes and macrophages by CD163-targeted
corosolic acid-containing liposomes. Cancer Immunol Immunother.
68:489–502. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Wanderley CW, Colón DF, Luiz JPM, Oliveira
FF, Viacava PR, Leite CA, Pereira JA, Silva CM, Silva CR, Silva RL,
et al: Paclitaxel reduces tumor growth by reprogramming
tumor-associated macrophages to an M1 profile in a TLR4-dependent
manner. Cancer Res. 78:5891–5900. 2018.PubMed/NCBI
|
|
86
|
Locatelli SL, Careddu G, Serio S, Consonni
FM, Maeda A, Viswanadha S, Vakkalanka S, Castagna L, Santoro A,
Allavena P, et al: Targeting cancer cells and tumor
microenvironment in preclinical and clinical models of Hodgkin
lymphoma using the dual PI3Kδ/γ inhibitor RP6530. Clin Cancer Res.
25:1098–1112. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Tan HY, Wang N, Man K, Tsao SW, Che CM and
Feng Y: Autophagy-induced RelB/p52 activation mediates
tumour-associated macrophage repolarisation and suppression of
hepatocellular carcinoma by natural compound baicalin. Cell Death
Dis. 6:e19422015. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Medler TR, Murugan D, Horton W, Kumar S,
Cotechini T, Forsyth AM, Leyshock P, Leitenberger JJ, Kulesz-Martin
M, Margolin AA, et al: Complement C5a fosters squamous
carcinogenesis and limits t cell response to chemotherapy. Cancer
Cell. 34:561–578.e6. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Guerriero JL, Sotayo A, Ponichtera HE,
Castrillon JA, Pourzia AL, Schad S, Johnson SF, Carrasco RD, Lazo
S, Bronson RT, et al: Class IIa HDAC inhibition reduces breast
tumours and metastases through anti-tumour macrophages. Nature.
543:428–432. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Zhang W, Wang M, Tang W, Wen R, Zhou S,
Lee C, Wang H, Jiang W, Delahunty IM, Zhen Z, et al:
Nanoparticle-laden macrophages for tumor-tropic drug delivery. Adv
Mater. 30:e18055572018. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Choi J, Kim HY, Ju EJ, Jung J, Park J,
Chung HK, Lee JS, Lee JS, Park HJ, Song SY, et al: Use of
macrophages to deliver therapeutic and imaging contrast agents to
tumors. Biomaterials. 33:4195–4203. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Opperman KS, Vandyke K, Clark KC, Coulter
EA, Hewett DR, Mrozik KM, Schwarz N, Evdokiou A, Croucher PI,
Psaltis PJ, et al: Clodronate-liposome mediated macrophage
depletion abrogates multiple myeloma tumor establishment in vivo.
Neoplasia. 21:777–787. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Zhang F, Parayath NN, Ene CI, Stephan SB,
Koehne AL, Coon ME, Holland EC and Stephan MT: Genetic programming
of macrophages to perform anti-tumor functions using targeted mRNA
nanocarriers. Nat Commun. 10:39742019. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Buhtoiarov IN, Sondel PM, Wigginton JM,
Buhtoiarova TN, Yanke EM, Mahvi DA and Rakhmilevich AL: Anti-tumour
synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN
immunotherapy through repolarization of tumour-associated
macrophages. Immunology. 132:226–239. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Di Caro G, Cortese N, Castino GF, Grizzi
F, Gavazzi F, Ridolfi C, Capretti G, Mineri R, Todoric J, Zerbi A,
et al: Dual prognostic significance of tumour-associated
macrophages in human pancreatic adenocarcinoma treated or untreated
with chemotherapy. Gut. 65:1710–1720. 2016. View Article : Google Scholar : PubMed/NCBI
|
